Tissuecypher® test results can increase the likelihood of appropriate management decisions for barrett's esophagus patients with low-grade dysplasia

Friendswood, texas--(business wire)---- $cstl #barrettsesophagus--castle announced new data from a patient simulation study involving the tissuecypher® test that will be shared during the esge days 2023 meeting.

CSTL Ratings Summary

CSTL Quant Ranking